CN Stock MarketDetailed Quotes

601607 Shanghai Pharmaceuticals Holding

Watchlist
  • 21.75
  • -0.07-0.32%
Market Closed Nov 29 15:00 CST
80.58BMarket Cap20.01P/E (TTM)

Shanghai Pharmaceuticals Holding Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Assets
Current assets
Money funds
15.58%33.82B
17.04%36.68B
11.09%30.04B
11.37%30.52B
14.80%29.26B
17.38%31.34B
-26.18%27.04B
22.38%27.4B
10.54%25.49B
16.54%26.7B
Transactional financial assets
-24.91%8.56B
-37.27%7.18B
-35.54%7.14B
5.60%10.15B
-9.37%11.4B
7.90%11.44B
--11.07B
--9.61B
--12.58B
--10.6B
Notes receivable and accounts receivable
9.12%84.49B
4.86%82.66B
8.73%82.94B
9.16%74.84B
5.44%77.43B
18.91%78.82B
18.01%76.28B
15.45%68.56B
20.11%73.43B
12.82%66.29B
-Notes receivable
11.73%1.42B
21.23%1.71B
21.70%1.69B
6.06%1.91B
7.63%1.27B
16.06%1.41B
18.96%1.39B
40.72%1.8B
352.47%1.18B
330.06%1.21B
-Accounts receivable
9.08%83.07B
4.56%80.95B
8.49%81.25B
9.25%72.93B
5.40%76.16B
18.96%77.41B
18.00%74.89B
14.89%66.76B
18.69%72.25B
11.29%65.08B
Other receivables (including interest and dividends)
16.71%3.19B
-2.69%3.43B
20.19%2.96B
31.32%3.38B
23.00%2.73B
13.09%3.53B
13.14%2.46B
6.44%2.57B
-8.04%2.22B
4.34%3.12B
-Dividend receivable
-49.90%195.97M
-39.08%302.78M
342.40%239.15M
339.48%239.07M
5,027.82%391.14M
1,834.68%497M
-10.00%54.06M
--54.4M
-59.84%7.63M
--25.69M
Advance payment
-45.73%3.12B
-0.82%3.63B
28.23%7.2B
-17.52%3.19B
86.54%5.75B
14.80%3.66B
62.92%5.62B
57.36%3.87B
-21.99%3.08B
23.10%3.19B
Inventories
7.21%37.58B
6.36%35.26B
5.26%33.84B
6.28%36.62B
23.62%35.05B
19.42%33.15B
26.36%32.15B
27.14%34.46B
17.44%28.35B
18.33%27.76B
Receivable financing
-19.50%1.56B
0.59%1.57B
49.01%2.31B
42.57%2.32B
35.04%1.94B
7.52%1.56B
-3.63%1.55B
0.52%1.63B
-38.41%1.44B
-33.61%1.45B
Non-current assets due within one year
-45.28%50.88M
-65.59%53.9M
-66.77%53.72M
-58.29%77.42M
38.10%92.99M
18.48%156.64M
33.13%161.66M
46.73%185.62M
8.87%67.34M
109.59%132.21M
Other current assets
46.37%1.41B
2.40%1.15B
10.67%921.44M
8.93%1.33B
20.50%964.47M
45.52%1.12B
4.07%832.59M
23.32%1.22B
-10.77%800.38M
-20.41%772.57M
Total current assets
5.56%173.79B
4.14%171.6B
6.51%167.41B
8.64%162.43B
11.63%164.63B
17.69%164.78B
16.54%157.17B
28.34%149.51B
24.97%147.47B
22.90%140.01B
Non Current assets
Other equity investment
3.22%55.53M
18.06%66.57M
25.06%66.12M
-45.40%55.42M
14.62%53.8M
8.31%56.38M
-0.25%52.87M
38.28%101.49M
-8.30%46.93M
2.78%52.06M
Other non-current financial assets
3.13%2.19B
2.33%2.22B
1.37%2.19B
2.44%2.2B
58.89%2.12B
57.06%2.17B
63.32%2.16B
54.30%2.14B
-7.18%1.34B
22.66%1.38B
Investment real estate
14.21%340.38M
38.49%332.45M
48.93%336.48M
27.70%314.67M
45.25%298.04M
18.54%240.06M
9.31%225.93M
15.51%246.42M
-11.82%205.19M
-15.42%202.51M
Long-term equity investment
-4.90%8.13B
-4.95%8.15B
-8.99%8.55B
-9.54%8.35B
-11.69%8.55B
-10.65%8.58B
-0.43%9.4B
1.76%9.23B
3.76%9.69B
3.86%9.6B
Long term receivable account
188.52%574.4M
196.99%596.54M
10.47%225.74M
7.37%227.94M
-13.18%199.09M
1.99%200.86M
-5.63%204.35M
7.36%212.3M
-10.82%229.32M
-16.55%196.94M
Fixed assets
----
4.45%11.81B
----
----
----
12.67%11.31B
----
10.06%11.54B
----
-2.33%10.04B
Constru in process
----
25.76%4.37B
----
----
----
2.00%3.47B
----
-4.69%2.78B
----
49.79%3.4B
Productive biological assets
-0.02%133.9M
-0.27%134.88M
0.61%135.97M
-2.74%133.43M
-66.53%133.93M
-66.29%135.25M
-66.40%135.14M
-65.92%137.19M
-1.38%400.13M
-1.15%401.25M
Intangible assets
-3.93%5.75B
-5.00%5.81B
-3.72%5.88B
-3.10%6.05B
2.52%5.99B
2.72%6.12B
2.73%6.11B
3.22%6.24B
14.69%5.84B
19.19%5.96B
Development expenditure
-41.47%220.2M
-38.98%222.05M
-9.20%306.87M
-9.37%310.51M
20.51%376.21M
28.06%363.92M
39.57%337.97M
32.16%342.61M
80.26%312.19M
45.81%284.18M
Goodwill
0.22%11.41B
0.05%11.39B
0.49%11.39B
0.51%11.39B
1.29%11.38B
1.31%11.39B
0.83%11.33B
0.86%11.34B
-0.37%11.24B
-0.39%11.24B
Long deferred expense
-14.15%437.41M
-15.71%435.84M
-2.58%460.97M
2.65%474.71M
33.10%509.53M
33.41%517.07M
12.83%473.16M
7.77%462.44M
0.72%382.83M
6.68%387.57M
Deferred tax assets
16.09%1.81B
10.28%1.76B
20.49%1.87B
11.87%1.72B
10.07%1.56B
12.14%1.6B
13.85%1.55B
12.23%1.53B
-2.76%1.41B
0.40%1.43B
Usufruct assets
12.42%2.1B
5.41%2.03B
7.94%2.07B
14.97%2.15B
-2.14%1.87B
-3.96%1.92B
-1.57%1.92B
-6.21%1.87B
3.62%1.91B
4.19%2B
Other non current assets
-18.29%307.42M
-14.63%400.51M
-4.70%384.8M
-0.70%440.69M
-13.75%376.22M
-17.28%469.15M
-45.93%403.79M
-48.21%443.8M
1.74%436.2M
21.37%567.17M
Total non current assets
2.96%49.95B
2.47%49.73B
2.35%50.01B
1.89%49.54B
2.92%48.52B
2.97%48.54B
3.63%48.87B
3.58%48.62B
4.10%47.14B
5.93%47.14B
Total assets
4.97%223.74B
3.76%221.34B
5.52%217.42B
6.98%211.97B
9.52%213.15B
13.98%213.32B
13.19%206.04B
21.23%198.13B
19.18%194.62B
18.13%187.15B
Liabilities
Current liabilities
Short term loan
10.61%38.81B
20.12%40.51B
15.76%37.41B
28.14%35.56B
19.68%35.08B
16.29%33.72B
17.92%32.32B
23.26%27.75B
27.63%29.31B
33.20%29B
Notes payable and accounts payable
4.72%61.69B
4.08%58.46B
7.18%57.35B
5.95%54.63B
19.68%58.91B
25.47%56.16B
24.83%53.51B
22.79%51.57B
12.33%49.22B
9.25%44.76B
-Notes payable
1.70%6.76B
1.05%6.18B
1.37%6.29B
12.68%6.72B
39.31%6.65B
39.60%6.11B
39.63%6.2B
25.12%5.96B
3.98%4.77B
-5.41%4.38B
-Accounts payable
5.10%54.93B
4.45%52.28B
7.94%51.07B
5.07%47.92B
17.57%52.26B
23.93%50.05B
23.12%47.31B
22.49%45.6B
13.31%44.45B
11.12%40.39B
Contract liabilities
48.10%1.44B
-12.26%1.26B
-18.58%1.6B
-12.13%1.97B
-18.40%973.57M
17.92%1.44B
148.70%1.97B
71.09%2.24B
-1.15%1.19B
-15.87%1.22B
Salaries payable
13.60%1.59B
0.87%1.43B
13.06%1.3B
12.88%1.78B
16.45%1.4B
27.87%1.41B
19.73%1.15B
10.29%1.58B
14.52%1.2B
15.04%1.11B
Taxs payable
-8.55%952.11M
-32.03%880.42M
-3.06%1.23B
-15.52%1.22B
2.36%1.04B
1.89%1.3B
-0.22%1.27B
-14.88%1.44B
0.62%1.02B
24.73%1.27B
Other payable (including interest and dividends)
6.21%16.9B
-8.64%18.16B
5.61%16.62B
8.95%17.95B
10.14%15.92B
30.82%19.87B
31.45%15.74B
26.12%16.47B
9.39%14.45B
6.13%15.19B
-Dividend payable
-0.04%319.62M
-32.56%1.75B
-11.81%245.17M
-33.77%247.13M
54.63%319.74M
37.55%2.6B
-23.38%278.02M
9.24%373.13M
-36.48%206.77M
20.39%1.89B
Non current liabilities due within one year
-34.39%1.93B
-46.90%2.25B
67.77%3.57B
-8.80%2.96B
60.71%2.94B
259.91%4.23B
176.54%2.13B
458.28%3.25B
-52.00%1.83B
-82.74%1.18B
Other current liabilities
0.65%6.21B
-0.58%6.16B
-0.55%6.18B
-1.46%6.29B
-32.70%6.17B
-0.20%6.2B
-32.23%6.21B
-30.84%6.38B
52.12%9.17B
23.64%6.21B
Total current liabilities
5.80%129.53B
3.83%129.1B
9.60%125.27B
10.55%122.37B
14.00%122.43B
24.41%124.34B
20.05%114.3B
20.55%110.69B
15.36%107.4B
8.24%99.94B
Current liabilities
Long term loan
2.70%7.69B
-3.94%6.6B
-22.98%6.62B
-7.57%5.79B
13.21%7.49B
-10.81%6.87B
21.79%8.6B
-12.55%6.26B
-2.75%6.61B
129.30%7.7B
Long term salaries pay
-34.41%25.16M
27.62%49.5M
-2.50%37.1M
-0.07%38.88M
2.12%38.35M
0.98%38.79M
2.13%38.05M
-0.24%38.91M
-0.22%37.55M
-3.75%38.41M
Estimate liabilities
51.22%40.52M
41.81%37.23M
49.46%35.88M
65.08%39.59M
-46.38%26.8M
-48.30%26.26M
3.28%24.01M
3.16%23.98M
49.90%49.98M
97.13%50.78M
Deferred tax liabilities
-5.56%876.71M
-0.14%984.21M
1.56%998.51M
-3.18%1.02B
-20.84%928.28M
-15.56%985.58M
-0.05%983.17M
5.05%1.05B
16.13%1.17B
12.63%1.17B
Long term deferred income
9.53%589.68M
11.35%626.65M
12.38%633.16M
18.50%633.48M
17.08%538.35M
13.39%562.76M
-75.38%563.42M
-77.24%534.58M
-79.65%459.8M
-78.70%496.28M
Lease liabilities
23.31%1.62B
13.23%1.5B
8.02%1.51B
19.09%1.55B
-23.35%1.31B
-9.82%1.32B
-1.43%1.4B
-9.25%1.3B
19.85%1.71B
0.96%1.47B
Other non current liabilities
-13.26%201.73M
-9.82%200.09M
-12.57%207.9M
-10.16%202.4M
-9.08%232.58M
-12.59%221.87M
-19.43%237.79M
-1.05%225.29M
26.39%255.82M
11.12%253.83M
Total non current liabilities
4.53%11.05B
-0.32%10B
-15.14%10.06B
-1.77%9.27B
-0.29%10.57B
-12.66%10.04B
-4.64%11.85B
-24.74%9.44B
-12.22%10.6B
30.59%11.49B
Total liabilities
5.70%140.58B
3.52%139.11B
7.27%135.33B
9.58%131.65B
12.71%133B
20.59%134.38B
17.20%126.15B
15.10%120.13B
12.19%118B
10.18%111.43B
Shareholders equity
Paid-in capital
0.04%3.7B
0.01%3.7B
0.13%3.7B
0.16%3.7B
0.19%3.7B
0.18%3.7B
0.08%3.7B
30.10%3.7B
30.06%3.7B
30.06%3.7B
Capital reserve funds
0.53%29.32B
0.34%29.26B
0.25%29.19B
0.31%29.19B
-0.41%29.17B
-0.14%29.16B
-0.19%29.11B
81.06%29.1B
82.89%29.29B
82.48%29.21B
Surplus reserve funds
6.86%2.31B
6.86%2.31B
6.86%2.31B
6.86%2.31B
8.35%2.16B
8.35%2.16B
8.35%2.16B
8.35%2.16B
9.11%1.99B
9.11%1.99B
Retained profit
6.01%36.06B
7.36%35.25B
4.02%35.36B
4.13%33.82B
7.29%34.02B
6.80%32.83B
13.90%34B
13.57%32.48B
12.55%31.71B
12.78%30.74B
Other composite income
1.45%-530.94M
-6.07%-528.5M
-24.66%-501M
-33.60%-496.09M
-5.68%-538.76M
-62.42%-498.24M
-117.35%-401.88M
-157.16%-371.32M
-159.54%-509.78M
-42.91%-306.76M
Shareholders equity without minority interests
3.44%70.87B
3.91%69.99B
2.18%70.06B
2.18%68.52B
3.53%68.51B
3.11%67.36B
6.27%68.57B
35.87%67.06B
36.00%66.17B
36.91%65.33B
Minority interests
5.66%12.29B
5.65%12.24B
6.28%12.02B
7.88%11.8B
11.43%11.63B
11.48%11.58B
14.78%11.31B
12.70%10.94B
10.44%10.44B
8.53%10.39B
Total shareholder equity
3.76%83.16B
4.16%82.23B
2.76%82.09B
2.98%80.33B
4.60%80.14B
4.26%78.94B
7.40%79.88B
32.06%78B
31.84%76.62B
32.17%75.72B
Total liabilityies and equity
4.97%223.74B
3.76%221.34B
5.52%217.42B
6.98%211.97B
9.52%213.15B
13.98%213.32B
13.19%206.04B
21.23%198.13B
19.18%194.62B
18.13%187.15B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)
--
--
--
PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Assets
Current assets
Money funds 15.58%33.82B17.04%36.68B11.09%30.04B11.37%30.52B14.80%29.26B17.38%31.34B-26.18%27.04B22.38%27.4B10.54%25.49B16.54%26.7B
Transactional financial assets -24.91%8.56B-37.27%7.18B-35.54%7.14B5.60%10.15B-9.37%11.4B7.90%11.44B--11.07B--9.61B--12.58B--10.6B
Notes receivable and accounts receivable 9.12%84.49B4.86%82.66B8.73%82.94B9.16%74.84B5.44%77.43B18.91%78.82B18.01%76.28B15.45%68.56B20.11%73.43B12.82%66.29B
-Notes receivable 11.73%1.42B21.23%1.71B21.70%1.69B6.06%1.91B7.63%1.27B16.06%1.41B18.96%1.39B40.72%1.8B352.47%1.18B330.06%1.21B
-Accounts receivable 9.08%83.07B4.56%80.95B8.49%81.25B9.25%72.93B5.40%76.16B18.96%77.41B18.00%74.89B14.89%66.76B18.69%72.25B11.29%65.08B
Other receivables (including interest and dividends) 16.71%3.19B-2.69%3.43B20.19%2.96B31.32%3.38B23.00%2.73B13.09%3.53B13.14%2.46B6.44%2.57B-8.04%2.22B4.34%3.12B
-Dividend receivable -49.90%195.97M-39.08%302.78M342.40%239.15M339.48%239.07M5,027.82%391.14M1,834.68%497M-10.00%54.06M--54.4M-59.84%7.63M--25.69M
Advance payment -45.73%3.12B-0.82%3.63B28.23%7.2B-17.52%3.19B86.54%5.75B14.80%3.66B62.92%5.62B57.36%3.87B-21.99%3.08B23.10%3.19B
Inventories 7.21%37.58B6.36%35.26B5.26%33.84B6.28%36.62B23.62%35.05B19.42%33.15B26.36%32.15B27.14%34.46B17.44%28.35B18.33%27.76B
Receivable financing -19.50%1.56B0.59%1.57B49.01%2.31B42.57%2.32B35.04%1.94B7.52%1.56B-3.63%1.55B0.52%1.63B-38.41%1.44B-33.61%1.45B
Non-current assets due within one year -45.28%50.88M-65.59%53.9M-66.77%53.72M-58.29%77.42M38.10%92.99M18.48%156.64M33.13%161.66M46.73%185.62M8.87%67.34M109.59%132.21M
Other current assets 46.37%1.41B2.40%1.15B10.67%921.44M8.93%1.33B20.50%964.47M45.52%1.12B4.07%832.59M23.32%1.22B-10.77%800.38M-20.41%772.57M
Total current assets 5.56%173.79B4.14%171.6B6.51%167.41B8.64%162.43B11.63%164.63B17.69%164.78B16.54%157.17B28.34%149.51B24.97%147.47B22.90%140.01B
Non Current assets
Other equity investment 3.22%55.53M18.06%66.57M25.06%66.12M-45.40%55.42M14.62%53.8M8.31%56.38M-0.25%52.87M38.28%101.49M-8.30%46.93M2.78%52.06M
Other non-current financial assets 3.13%2.19B2.33%2.22B1.37%2.19B2.44%2.2B58.89%2.12B57.06%2.17B63.32%2.16B54.30%2.14B-7.18%1.34B22.66%1.38B
Investment real estate 14.21%340.38M38.49%332.45M48.93%336.48M27.70%314.67M45.25%298.04M18.54%240.06M9.31%225.93M15.51%246.42M-11.82%205.19M-15.42%202.51M
Long-term equity investment -4.90%8.13B-4.95%8.15B-8.99%8.55B-9.54%8.35B-11.69%8.55B-10.65%8.58B-0.43%9.4B1.76%9.23B3.76%9.69B3.86%9.6B
Long term receivable account 188.52%574.4M196.99%596.54M10.47%225.74M7.37%227.94M-13.18%199.09M1.99%200.86M-5.63%204.35M7.36%212.3M-10.82%229.32M-16.55%196.94M
Fixed assets ----4.45%11.81B------------12.67%11.31B----10.06%11.54B-----2.33%10.04B
Constru in process ----25.76%4.37B------------2.00%3.47B-----4.69%2.78B----49.79%3.4B
Productive biological assets -0.02%133.9M-0.27%134.88M0.61%135.97M-2.74%133.43M-66.53%133.93M-66.29%135.25M-66.40%135.14M-65.92%137.19M-1.38%400.13M-1.15%401.25M
Intangible assets -3.93%5.75B-5.00%5.81B-3.72%5.88B-3.10%6.05B2.52%5.99B2.72%6.12B2.73%6.11B3.22%6.24B14.69%5.84B19.19%5.96B
Development expenditure -41.47%220.2M-38.98%222.05M-9.20%306.87M-9.37%310.51M20.51%376.21M28.06%363.92M39.57%337.97M32.16%342.61M80.26%312.19M45.81%284.18M
Goodwill 0.22%11.41B0.05%11.39B0.49%11.39B0.51%11.39B1.29%11.38B1.31%11.39B0.83%11.33B0.86%11.34B-0.37%11.24B-0.39%11.24B
Long deferred expense -14.15%437.41M-15.71%435.84M-2.58%460.97M2.65%474.71M33.10%509.53M33.41%517.07M12.83%473.16M7.77%462.44M0.72%382.83M6.68%387.57M
Deferred tax assets 16.09%1.81B10.28%1.76B20.49%1.87B11.87%1.72B10.07%1.56B12.14%1.6B13.85%1.55B12.23%1.53B-2.76%1.41B0.40%1.43B
Usufruct assets 12.42%2.1B5.41%2.03B7.94%2.07B14.97%2.15B-2.14%1.87B-3.96%1.92B-1.57%1.92B-6.21%1.87B3.62%1.91B4.19%2B
Other non current assets -18.29%307.42M-14.63%400.51M-4.70%384.8M-0.70%440.69M-13.75%376.22M-17.28%469.15M-45.93%403.79M-48.21%443.8M1.74%436.2M21.37%567.17M
Total non current assets 2.96%49.95B2.47%49.73B2.35%50.01B1.89%49.54B2.92%48.52B2.97%48.54B3.63%48.87B3.58%48.62B4.10%47.14B5.93%47.14B
Total assets 4.97%223.74B3.76%221.34B5.52%217.42B6.98%211.97B9.52%213.15B13.98%213.32B13.19%206.04B21.23%198.13B19.18%194.62B18.13%187.15B
Liabilities
Current liabilities
Short term loan 10.61%38.81B20.12%40.51B15.76%37.41B28.14%35.56B19.68%35.08B16.29%33.72B17.92%32.32B23.26%27.75B27.63%29.31B33.20%29B
Notes payable and accounts payable 4.72%61.69B4.08%58.46B7.18%57.35B5.95%54.63B19.68%58.91B25.47%56.16B24.83%53.51B22.79%51.57B12.33%49.22B9.25%44.76B
-Notes payable 1.70%6.76B1.05%6.18B1.37%6.29B12.68%6.72B39.31%6.65B39.60%6.11B39.63%6.2B25.12%5.96B3.98%4.77B-5.41%4.38B
-Accounts payable 5.10%54.93B4.45%52.28B7.94%51.07B5.07%47.92B17.57%52.26B23.93%50.05B23.12%47.31B22.49%45.6B13.31%44.45B11.12%40.39B
Contract liabilities 48.10%1.44B-12.26%1.26B-18.58%1.6B-12.13%1.97B-18.40%973.57M17.92%1.44B148.70%1.97B71.09%2.24B-1.15%1.19B-15.87%1.22B
Salaries payable 13.60%1.59B0.87%1.43B13.06%1.3B12.88%1.78B16.45%1.4B27.87%1.41B19.73%1.15B10.29%1.58B14.52%1.2B15.04%1.11B
Taxs payable -8.55%952.11M-32.03%880.42M-3.06%1.23B-15.52%1.22B2.36%1.04B1.89%1.3B-0.22%1.27B-14.88%1.44B0.62%1.02B24.73%1.27B
Other payable (including interest and dividends) 6.21%16.9B-8.64%18.16B5.61%16.62B8.95%17.95B10.14%15.92B30.82%19.87B31.45%15.74B26.12%16.47B9.39%14.45B6.13%15.19B
-Dividend payable -0.04%319.62M-32.56%1.75B-11.81%245.17M-33.77%247.13M54.63%319.74M37.55%2.6B-23.38%278.02M9.24%373.13M-36.48%206.77M20.39%1.89B
Non current liabilities due within one year -34.39%1.93B-46.90%2.25B67.77%3.57B-8.80%2.96B60.71%2.94B259.91%4.23B176.54%2.13B458.28%3.25B-52.00%1.83B-82.74%1.18B
Other current liabilities 0.65%6.21B-0.58%6.16B-0.55%6.18B-1.46%6.29B-32.70%6.17B-0.20%6.2B-32.23%6.21B-30.84%6.38B52.12%9.17B23.64%6.21B
Total current liabilities 5.80%129.53B3.83%129.1B9.60%125.27B10.55%122.37B14.00%122.43B24.41%124.34B20.05%114.3B20.55%110.69B15.36%107.4B8.24%99.94B
Current liabilities
Long term loan 2.70%7.69B-3.94%6.6B-22.98%6.62B-7.57%5.79B13.21%7.49B-10.81%6.87B21.79%8.6B-12.55%6.26B-2.75%6.61B129.30%7.7B
Long term salaries pay -34.41%25.16M27.62%49.5M-2.50%37.1M-0.07%38.88M2.12%38.35M0.98%38.79M2.13%38.05M-0.24%38.91M-0.22%37.55M-3.75%38.41M
Estimate liabilities 51.22%40.52M41.81%37.23M49.46%35.88M65.08%39.59M-46.38%26.8M-48.30%26.26M3.28%24.01M3.16%23.98M49.90%49.98M97.13%50.78M
Deferred tax liabilities -5.56%876.71M-0.14%984.21M1.56%998.51M-3.18%1.02B-20.84%928.28M-15.56%985.58M-0.05%983.17M5.05%1.05B16.13%1.17B12.63%1.17B
Long term deferred income 9.53%589.68M11.35%626.65M12.38%633.16M18.50%633.48M17.08%538.35M13.39%562.76M-75.38%563.42M-77.24%534.58M-79.65%459.8M-78.70%496.28M
Lease liabilities 23.31%1.62B13.23%1.5B8.02%1.51B19.09%1.55B-23.35%1.31B-9.82%1.32B-1.43%1.4B-9.25%1.3B19.85%1.71B0.96%1.47B
Other non current liabilities -13.26%201.73M-9.82%200.09M-12.57%207.9M-10.16%202.4M-9.08%232.58M-12.59%221.87M-19.43%237.79M-1.05%225.29M26.39%255.82M11.12%253.83M
Total non current liabilities 4.53%11.05B-0.32%10B-15.14%10.06B-1.77%9.27B-0.29%10.57B-12.66%10.04B-4.64%11.85B-24.74%9.44B-12.22%10.6B30.59%11.49B
Total liabilities 5.70%140.58B3.52%139.11B7.27%135.33B9.58%131.65B12.71%133B20.59%134.38B17.20%126.15B15.10%120.13B12.19%118B10.18%111.43B
Shareholders equity
Paid-in capital 0.04%3.7B0.01%3.7B0.13%3.7B0.16%3.7B0.19%3.7B0.18%3.7B0.08%3.7B30.10%3.7B30.06%3.7B30.06%3.7B
Capital reserve funds 0.53%29.32B0.34%29.26B0.25%29.19B0.31%29.19B-0.41%29.17B-0.14%29.16B-0.19%29.11B81.06%29.1B82.89%29.29B82.48%29.21B
Surplus reserve funds 6.86%2.31B6.86%2.31B6.86%2.31B6.86%2.31B8.35%2.16B8.35%2.16B8.35%2.16B8.35%2.16B9.11%1.99B9.11%1.99B
Retained profit 6.01%36.06B7.36%35.25B4.02%35.36B4.13%33.82B7.29%34.02B6.80%32.83B13.90%34B13.57%32.48B12.55%31.71B12.78%30.74B
Other composite income 1.45%-530.94M-6.07%-528.5M-24.66%-501M-33.60%-496.09M-5.68%-538.76M-62.42%-498.24M-117.35%-401.88M-157.16%-371.32M-159.54%-509.78M-42.91%-306.76M
Shareholders equity without minority interests 3.44%70.87B3.91%69.99B2.18%70.06B2.18%68.52B3.53%68.51B3.11%67.36B6.27%68.57B35.87%67.06B36.00%66.17B36.91%65.33B
Minority interests 5.66%12.29B5.65%12.24B6.28%12.02B7.88%11.8B11.43%11.63B11.48%11.58B14.78%11.31B12.70%10.94B10.44%10.44B8.53%10.39B
Total shareholder equity 3.76%83.16B4.16%82.23B2.76%82.09B2.98%80.33B4.60%80.14B4.26%78.94B7.40%79.88B32.06%78B31.84%76.62B32.17%75.72B
Total liabilityies and equity 4.97%223.74B3.76%221.34B5.52%217.42B6.98%211.97B9.52%213.15B13.98%213.32B13.19%206.04B21.23%198.13B19.18%194.62B18.13%187.15B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)------PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data